ArticleF1000Research2025
Ameliorative Effects of Ethyl-Acetate Extract of
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exploratory Review on Male Fertility Potential of Acetyl-Eugenol: Mechanistic Insights, Experimental Evidence, and Therapeutic Prospects.Journal of experimental pharmacology · 2026Review
- Article
- Exploring the Neuroprotective Potentials of Flavonoid Metabolites inJournal of experimental pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bisphenol A (BPA), a ubiquitous environmental pollutant, is known to induce oxidative stress and disrupt male reproductive function. This study evaluated the ameliorative effects of the ethyl-acetate extract of Method: GC-MS phytocompounds from EABP were subjected to Result: Molecular docking analysis revealed that 9,12,15-octadecatrienoic acid, a key phytoconstituent of EABP, exhibited strong binding affinity for both the androgen receptor (AR) and nuclear factor erythroid 2-related factor 2 (NRF2). Its interaction with AR was comparable to that of testosterone, suggesting potential androgenic activity, while its binding to NRF2 mirrored that of vitamin C. The extract's antioxidant activity was further supported by the DPPH radical scavenging assay, where it demonstrated moderate potency with an IC₅₀ of 6.11μg/mL, compared to 1.25μg/mL for vitamin C. in vivo findings showed that treatment with EABP at 250 mg/kg, 500 mg/kg, and 1000 mg/kg restored SOD activity and significantly reduced MDA levels. Catalase (CAT) activity also improved, particularly at the higher dose. Conclusion: Collectively, these results indicate that the EABP offers protective effects against BPA-induced oxidative stress, metabolic disturbance, and reproductive dysfunction, possibly through its combined antioxidant and hormone-like properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.